Letters to the Editor
26 January 2016
Vol. 69 No. 2 (2008): Pulmonary series
Does 18F-fluorodeoxyglucose PET/CT have a role in the management of pulmonary and extra pulmonary sarcoidosis?
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
518
Views
385
Downloads
Authors
Altmetrics
Downloads
Download data is not yet available.
Citations
How to Cite
“Does 18F-Fluorodeoxyglucose PET CT Have a Role in the Management of Pulmonary and Extra Pulmonary Sarcoidosis?”. 2016. Monaldi Archives for Chest Disease 69 (2). https://doi.org/10.4081/monaldi.2008.402.